1
|
Monson E, Arney D, Benham B, Bird R, Elias E, Linden K, McCord K, Miller C, Miller T, Ritter L, Waggy D. Beyond Pills: Acupressure Impact on Self-Rated Pain and Anxiety Scores. J Altern Complement Med 2019; 25:517-521. [PMID: 30932686 PMCID: PMC6533784 DOI: 10.1089/acm.2018.0422] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Objectives: To determine impact of an acupressure protocol on self-rated pain and anxiety scores. Design: Retrospective database analysis of self-rated pain and anxiety scores before and immediately after administration of stress release acupressure protocol. Participants: Participants include hospitalized patients, nurses, and public. Intervention: Involves a 16-point stress release acupressure protocol. Outcome measures: Outcome measures involve pre- and post-treatment self-rated pain scores (0-10) with the Wong-Baker Faces Scale and pre- and post-treatment self-rated anxiety scores (0-10) on a visual analog scale. Results: Five hundred and nineteen acupressure treatments were retrospectively analyzed with pre- and post-treatment self-rated pain and anxiety scores, where 0 represented no pain or anxiety and 10 represented the worst pain and anxiety. Overall, participants demonstrated a two-point decrease in pain scores and a four-point decrease in anxiety scores post-treatment. Hospitalized patients demonstrated a four-point decrease in pain scores and a five-point decrease in anxiety scores post-treatment. Nurses demonstrated a three-point decrease in pain scores and four-point decrease in anxiety scores post-treatment. Public population demonstrated a one-point decrease in pain scores and two-point decrease in anxiety scores post-treatment. Seventy-five percent of participants were highly satisfied with acupressure treatments, and 96% of treatments were administered in less than 30 minutes. Conclusions: Acupressure is a highly satisfactory complementary therapy that can demonstrate a clinically significant decrease in self-rated pain and anxiety scores.
Collapse
Affiliation(s)
- Elizabeth Monson
- 1 Heart Failure/Transplant, Intermountain Medical Center, Salt Lake City, Utah
| | | | - Beth Benham
- 3 Soul Lightening International, New Hampshire
| | - Rebekah Bird
- 4 Good Samaritan Regional Medical Center, Corvallis, Oregon
| | - Erika Elias
- 4 Good Samaritan Regional Medical Center, Corvallis, Oregon
| | - Kami Linden
- 4 Good Samaritan Regional Medical Center, Corvallis, Oregon
| | | | - Cathy Miller
- 5 Soul Lightening International, Goldsboro, Maryland
| | - Tammy Miller
- 4 Good Samaritan Regional Medical Center, Corvallis, Oregon
| | - Lori Ritter
- 4 Good Samaritan Regional Medical Center, Corvallis, Oregon
| | - Deanna Waggy
- 6 Soul Lightening International, South Bend, Indiana
| |
Collapse
|
2
|
Speich B, Schur N, Gryaznov D, von Niederhäusern B, Hemkens LG, Schandelmaier S, Amstutz A, Kasenda B, Pauli-Magnus C, Ojeda-Ruiz E, Tomonaga Y, McCord K, Nordmann A, von Elm E, Briel M, Schwenkglenks M. Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation. PLoS One 2019; 14:e0210669. [PMID: 30633776 PMCID: PMC6329511 DOI: 10.1371/journal.pone.0210669] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2018] [Accepted: 12/28/2018] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND The preparation of a randomized controlled trial (RCT) requires substantial resources and the administrative processes can be burdensome. To facilitate the conduct of RCTs it is important to better understand cost drivers. In January 2014 the enactment of the new Swiss Legislation on Human Research (LHR) considerably changed the regulatory framework in Switzerland. We assess if the new LHR was associated with change in (i) resource use and costs to prepare an RCT, and (ii) approval times with research ethics committees (RECs) and the regulatory authority Swissmedic. METHODS We surveyed investigators of RCTs which were approved by RECs in 2012 or in 2016 and asked for RCT preparation costs using a pre-specified item list. Additionally, we collected approval times from RECs and Swissmedic. RESULTS The response rates of the investigator survey were 8.3% (19/228) for 2012 and 16.5% (47/285) in 2016. The median preparation cost of an RCT was USD 72,400 (interquartile range [IQR]: USD 59,500-87,700; n = 18) in 2012 and USD 72,600 (IQR: USD 42,800-169,600; n = 35) in 2016. For single centre RCTs a median REC approval time of 82 (IQR: 49-107; n = 38) days in 2012 and 92 (IQR: 65-131; n = 63) days in 2016 was observed. The median Swissmedic approval time for any clinical trial was 27 (IQR: 19-51; n = 213) days in 2012 and 49 (IQR: 36-67; n = 179) days in 2016. The total duration for achieving RCT approval from both authorities (REC and Swissmedic) in the parallel submission procedure applied in 2016 could not be assessed. CONCLUSION Based on limited data the costs to plan and prepare RCTs in Switzerland were approximately USD 72,000 in 2012 and 2016. For effective and valid research on costs and approval times of RCTs a greater willingness to share cost information among investigators and more collaboration between stakeholders with data linkage is necessary.
Collapse
Affiliation(s)
- Benjamin Speich
- Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Nadine Schur
- Institute of Pharmaceutical Medicine, University of Basel, Basel, Switzerland
| | - Dmitry Gryaznov
- Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Belinda von Niederhäusern
- Clinical Trial Unit, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Lars G. Hemkens
- Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Stefan Schandelmaier
- Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
| | - Alain Amstutz
- Swiss Tropical and Public Health Institute, and Division of Infectious Diseases and Hospital Epidemiology, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Benjamin Kasenda
- Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
- Department of Medical Oncology, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Christiane Pauli-Magnus
- Clinical Trial Unit, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Elena Ojeda-Ruiz
- National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain
| | - Yuki Tomonaga
- Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland
| | - Kimberly McCord
- Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Alain Nordmann
- Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
| | - Erik von Elm
- Cochrane Switzerland, Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland
| | - Matthias Briel
- Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
| | - Matthias Schwenkglenks
- Institute of Pharmaceutical Medicine, University of Basel, Basel, Switzerland
- Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland
| | | |
Collapse
|
3
|
McCord K, Morley P, Armstrong J, Simpson K, Rishniw M, Forman M, Biller D, Parnell N, Arnell K, Hill S, Avgeris S, Gittelman H, Moore M, Hitt M, Oswald G, Marks S, Burney D, Twedt D. A Multi-Institutional Study Evaluating the Diagnostic Utility of the Spec cPL™ and SNAP® cPL™ in Clinical Acute Pancreatitis in 84 Dogs. J Vet Intern Med 2012; 26:888-96. [DOI: 10.1111/j.1939-1676.2012.00951.x] [Citation(s) in RCA: 76] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2011] [Revised: 03/27/2012] [Accepted: 04/24/2012] [Indexed: 11/26/2022] Open
Affiliation(s)
- K. McCord
- Colorado State University; Fort Collins; CO
| | | | | | | | | | | | - D. Biller
- Kansas State University; Manhattan; KS
| | | | - K. Arnell
- Veterinary Specialty Hospital; San Diego; CA
| | - S. Hill
- Veterinary Specialty Hospital; San Diego; CA
| | - S. Avgeris
- Atlanta Veterinary Imaging and Diagnostics; Atlanta; GA
| | | | - M. Moore
- VCA All Care Referral Center; Fountain Valley; CA
| | - M. Hitt
- Atlantic Internal Medicine; Annapolis; MD
| | - G. Oswald
- Tampa Bay Veterinary Specialists; Largo; FL
| | - S. Marks
- University of California-Davis; Davis; CA
| | - D. Burney
- Gulf Coast Veterinary Specialists; Houston; TX
| | - D. Twedt
- Colorado State University; Fort Collins; CO
| |
Collapse
|
4
|
Harvald B, McCord K. [Axel Laurent-Christensen: a doctor "with feeling for snow"]. Dan Medicinhist Arbog 2002:9-51. [PMID: 11826902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
In 1950 the district medical officer of Qaqortoq/Julianehåb, Axel Laurent-Christensen retired after having served in this position since 1930. Afterwards, during the years 1950-55, he was a medical officer in Aklavik, NWT, Canada. Here he had the opportunity to compare the arctic Canadian health care with the Greenland health care system. In his diary, of which selected parts are given in the present paper, he has commented on the differences. In the 1950's the Canadian system was highly centralized with the well-equipped Charles Camsell Indian Hospital in Edmonton as the center. The Greenland health service, on the other hand, was decentralized, based on small surgically staffed peripheral hospitals. The development of these two health care systems during the past 50 years has accentuated these differences. Estimated by the infant mortality, the efficiency of the Greenland health care system was superior to the Canadian during the 1950's, whereas in the 1990's, the Canadian health service is vastly superior.
Collapse
|